期刊文献+

抗血小板药物治疗期间血小板功能检测及临床应用的研究现状 被引量:4

Current situation of platelet function tests and their clinical application status during antiplatelet treatment
原文传递
导出
摘要 抗血小板药物(尤其是氯吡格雷)存在不同程度个体差异,可能导致不良临床事件发生。目前针对抗血小板药物治疗期间的血小板功能检测以评估预后并指导个体化给药的研究较多,但争论较大。本文就现有的血小板功能检测方法及其最新研究现状作一综合。 The pharmacodynamics of antiplatelet drugs,especially clopidogrel,vary among individuals,which may lead to the occurrence of adverse clinical events. Although there are a large number of studies that focus on using platelet function tests to access clinical outcome and guide individual antiplatelet therapies,the results remain controversial. This article reviews currently available platelet function assays and advances in clinical research.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第1期66-69,共4页 The Chinese Journal of Clinical Pharmacology
关键词 抗血小板药物 血小板功能检测 血小板高反应性 antiplatelet drug platelet reactivity test highon -treatment platelet reactivity
  • 相关文献

参考文献3

二级参考文献49

  • 1Levine GN,Bates ER,Blankenship JC,Bailey SR,Bittl JA,Cercek B,et al.2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention:A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions.Circulation 2011;124:e574-651.
  • 2CAPRIE Steering Committee.A randomised,blinded,trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).CAPRIE Steering Committee.Lancet 1996;348:1329-39.
  • 3Yusuf S,Zhao F,Mehta SR,Chrolavicius S,Tognoni G,Fox KK,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med 2001;345:494-502.
  • 4Steinhubl SR,Berger PB,Mann JT 3rd,Fry ET,DeLago A,Wilmer C,et al.Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:A randomized controlled trial.JAMA 2002;288:2411-20.
  • 5Campo G,Fileti L,Valgimigli M,Tebaldi M,Cangiano E,Cavazza C,et al.Poor response to clopidogrel:Current and future options for its management.J Thromb Thrombolysis 2010;30:319-31.
  • 6Cuschieri JR,Drawz P,Falck-Ytter Y,Wong RC.Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel.J Dig Dis 2014;15:195-201.
  • 7Morneau KM,Reaves AB,Martin JB,Oliphant CS.Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.J Manag Care Pharm 2014;20:187-93.
  • 8Frere C,Cuisset T,Morange PE,Quilici J,Camoin-Jau L,Saut N,et al.Effect ofcytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome.Am J Cardiol 2008;101:1088-93.
  • 9Hokimoto S,Mizobe M,Akasaka T,Arima Y,Kaikita K,Nakagawa K,et al.Impact of CYP2C 19 polymorphism and proton pump inhibitors on platelet reactivity to clopidogrel and clinical outcomes following stent implantation.Thromb Res 2014;133:599-605.
  • 10Hollopeter G,Jantzen HM,Vincent D,Li G,England L,Ramakrishnan V,et al.Identification of the platelet ADP receptor targeted by antithrombotic drugs.Nature 2001;409:202-7.

共引文献42

同被引文献26

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部